Newsletter | August 20, 2025

08.20.25 -- IP Law: In Defense Of Polymorphs

SPONSOR

 

 

Revolutionize your approach to clinical trials at DPHARM: Disruptive Innovations to Modernize Clinical Research, taking place September 16–17, 2025, in Philadelphia. This conference showcases cutting-edge strategies and technologies designed to reduce patient and site burden, streamline operations, improve data quality, and accelerate access to therapies. Use code LSL20 for 20% off your registration.

FEATURED ARTICLE

IP Law: In Defense Of Polymorphs

Polymorphs, or different crystalline forms of the same drug, can be selected for distinct properties and patented. A recent court ruling, however, adds new complexity, write experts at Finnegan.

 

INDUSTRY INSIGHTS

 

From Startup To Public Company: Scaling Finance Operations

When basic tools no longer support your growing company, robust systems, such as ERPs, become essential for managing complex financial reporting, regulatory compliance, and multi-entity tracking.

 

Corporate Recombinations Include $50M, New Life For Durham's Pelthos

Explore how Pelthos Therapeutics partners with Channel Therapeutics to launch its FDA-approved drug, backed by $50 million in new funding to strengthen its position in the global pharmaceutical market.

 

Digital Tools And Technologies Used To Improve Clinical Trial Recruitment

Digital clinical trial recruitment is revolutionizing patient engagement. Discover how cutting-edge technologies are reshaping recruitment strategies and transforming the future of global healthcare.

 

The Streetlight Effect

Examine the shortcomings of existing clinical trial finders, particularly regarding the accessibility of eligibility criteria for patients seeking treatment options.

 

Unlocking Potential: A Deep Dive Into AAV Development And Manufacturing

When it comes to furthering AAV's potential in the wider biopharmaceutical pipeline, partnering with a CDMO that can foment an optimal analytical and manufacturing strategy is crucial.

 

The Benefits Of U.S. Biotechs Conducting Clinical Trials In Australia

As U.S. biotech investment continues to rise, cross-border collaboration and trial design innovations are expected to further solidify Australia’s role in the early-stage biotech development pipeline.